Table 1.
Baseline clinical characteristics of Crohn’s disease [CD], ulcerative colitis [UC] and non-IBD patients included in the study
| Clinical characteristics | CD | UC | Non-IBD |
|---|---|---|---|
| Number of Patients, n | 65 | 31 | 16 |
| Male/female, n | 29/36 | 15/16 | 8/8 |
|
Age at enrolment,
year [mean ± SD] |
40 ± 7 | 41 ± 13 | 69 ± 12 |
|
Disease duration,
years [mean ± SD] |
11 ± 6 | 9 ± 5 | - |
| Concomitant therapy [n] | |||
| None | 25 | 23 | |
| Mesalamine | 8 | 4 | |
| Antibiotics | 2 | 0 | |
| Thiopurines | 9 | 0 | |
| Corticosteroids | 4 | 4 | |
| Infliximab | 12 | 0 | |
| Risankizumab | 5 | 0 | |
IBD, inflammatory bowel disease; SD, standard deviation.